Hemanext Is A Global Biomedical Technology Company Based In Lexingtonmassachusettsspecializing In Transfusion Medicinefounded In 1997The Company Is Dedicated To Enhancing The Qualitysafetyefficacyand Availability Of Blood Transfusions For Patients Worldwidehemanext Develops Innovative Processing And Storage Technologies For Red Blood Cellsrbcs Aiming To Improve Their Quality And Shelf Lifewhich Are Essential For Effective Transfusion Therapies The Company Has A Strong Commitment To Research And Developmentholding Numerous Patents Related To Blood And Transfusion Medicinehemanext S Products And Services Are Designed For Healthcare Providers And Institutions Involved In Transfusion Medicineincluding Hospitals And Blood Bankswith Significant Funding Of $134 6 Millionhemanext Is Well Positioned To Advance Its Mission Of Improving Patient Care Through Safer And More Effective Blood Transfusion Practices
